Results 201 to 210 of about 26,990 (251)

Prediction of incident heart failure in type 2 diabetes mellitus: Rationale and design of the DM‐HEART study

Journal of Diabetes Investigation, EarlyView.
ABSTRACT Preclinical heart failure (HF) (stages A and B) is common but easily overlooked in asymptomatic patients with type 2 diabetes (T2D). There is a paucity of evidence regarding how coexisting risk factors contribute to the development of HF in asymptomatic Asian patients with T2D, and there is a lack of guidance on the early identification of ...
Jiun‐Lu Lin, Yen‐Wen Wu, Sung‐Chen Liu, Chung‐Ming Tu, Heng‐Hsu Lin, Yi‐Fu Lin, Hao‐Yun Chang, Ming‐Nan Chien, Chih‐Yuan Wang, Chung‐Lieh Hung   +9 more
wiley   +1 more source

Plantar fascia thickness in type 1 diabetes mellitus patients: Clinical associations and metabolic correlates

Journal of Diabetes Investigation, EarlyView.
Ultrasound‐measured plantar fascia thickness is associated with microvascular complications and glycemic control in individuals with type 1 diabetes, suggesting PFT as a potential non‐invasive tool for clinical assessment. In addition, improved thickness values were observed in patients using automated insulin delivery systems.
Giulia Casadei, Michele Baldari, Lorenzo Brognara, Enrico Saudelli, Simona Moscatiello, Sara Flamigni, Francesco Traina, Alexandro Paccapelo, Uberto Pagotto, Guido Di Dalmazi   +9 more
wiley   +1 more source

Serum nonmercaptalbumin to total albumin ratio and bilirubin predict ADL decline in older adults with type 2 diabetes

Journal of Diabetes Investigation, EarlyView.
In a longitudinal cohort of older adults with type 2 diabetes, incident ADL disability was evaluated. Higher HNA%, lower serum bilirubin, and older age independently predicted the risk of disability. Their combined assessment may offer clinically useful tools for identifying individuals at elevated risk of functional deterioration.
Yukihiro Inoguchi, Toyoshi Inoguchi, Keiko Yasukawa, Saki Fukuhara, Tomoaki Etoh, Mitsunori Masakado, Mayumi Yamato, Fumio Umeda, Yutaka Yatomi, Teruaki Yamauchi, Masatoshi Nomura   +10 more
wiley   +1 more source

Monocyte dipeptidyl peptidase 4 activity is associated with urinary albumin excretion in type 2 diabetes

Journal of Diabetes Investigation, EarlyView.
This study examined whether dipeptidyl peptidase 4 (DPP4) characteristics in peripheral blood monocytes relate to renal parameters. Monocyte DPP4 activity was independently associated with urinary albumin excretion in patients with type 2 diabetes, suggesting that monocytes may function as a cellular link between DPP4 and diabetic kidney disease ...
Hideyuki Okuma, Takahiro Tsutsumi, Kyoichiro Tsuchiya   +2 more
wiley   +1 more source

Eosinophilia in the Tropics: Should Empirical Anthelmintic Treatment Be Considered Standard Practice? A Prospective Cohort Study

Tropical Medicine &International Health, EarlyView.
ABSTRACT Background Eosinophilia is a common clinical finding with diverse etiologies. Helminthiasis is a major aetiology in tropical regions, but data from haematology consultation services at tertiary centres in endemic settings are limited. Objectives To determine the prevalence of helminthiasis among patients with eosinophilia at a tropical ...
Smith Kungwankiattichai, Patsharaporn T. Sarasombath, Pattaraporn Tunsing, Weerapat Owattanapanich   +3 more
wiley   +1 more source

The role of ischemia-modified albumin, presepsin, delta neutrophil index, and inflammatory markers in diagnosing acute cholecystitis. [PDF]

Ulus Travma Acil Cerrahi Derg
Gedik MS, Kilci AI, Hakkoymaz H, Seyithanoğlu M, Orakçı MA, Basan NM, Aksu A, Küçük ÖF.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ischemia modified albumin in perinatology

European Journal of Obstetrics, Gynecology and Reproductive Biology, 2017
Ischemia modified albumin is a novel marker of ischemia generated due to hypooxygenation and increased hydroxyl free radicals in low pH. The molecule has been licenced for clinical use as an early marker for acute coronary syndrome in cardiology. Since presence of ischemia might have serious and sometimes devastating effects in perinatology, various ...
Asli Yarci Gursoy, Gamze Sinem Caglar
exaly   +3 more sources

Standardization of ischemia-modified albumin testing: adjustment for serum albumin

Clinical Chemistry and Laboratory Medicine, 2007
The diagnostic approach to acute myocardial infarction (AMI) is still one of the most challenging and controversial medical issues. Although the measurement of cardiospecific troponins has emerged as the gold standard for management of patients with acute chest pain, it is often unsuitable for early diagnosis, as nearly 50% of patients may present with
Giuseppe Lippi, Martina Montagnana, Gian Cesare Guidi   +2 more
exaly   +5 more sources

Ischemia-Modified Albumin in Gynecology

Biomarkers in Medicine, 2021
Background: Ischemia-modified albumin (IMA) is an oxidative stress marker used to assess the presence and severity of oxidative stress. This marker was first used for early diagnosis of myocardial ischemia. Materials & methods: A variety of IMA studies were carried out to show the effect of oxidative stress on gynecological disorders.
Mehmet F Kıncı, Burcu Kasap, Ahmet A Sivaslıoğlu   +2 more
openaire   +3 more sources

Ischemia modified albumin in pregnancy

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
In normal pregnancies, a hypoxic intrauterine environment seems necessary for early trophoblast development. In this context, maternal serum levels of ischemia-modified albumin (IMA) are elevated, reflecting the oxidative stress associated with placental development.
ROSSI, Alberto, ROMANELLO, Irene, FORZANO, Leonardo, GANZITTI, Laura, VOGRIG, Emanuela, MARCHESONI, Diego   +5 more
openaire   +8 more sources